文献速递食管胃疾病与幽门螺杆菌

幽门螺杆菌感染多种不同一线治疗方案的比较有效性:网络荟萃分析

Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.
PubMed 文献 · Gastroenterology · 2021-04-08

仅伏诺拉生三联疗法和反向混合疗法根除率超过90%。标准三联疗法效果最差。

要点

  • 伏诺拉生三联疗法和反向混合疗法根除率超过90%
  • 西方国家中左氧氟沙星三联疗法根除率最高,达88.5%
  • 标准三联疗法在8种方案中效果最差

核心结论

  • 伏诺拉生三联疗法和反向混合疗法一线经验性治疗幽门螺杆菌根除率超过90%
  • 西方国家中左氧氟沙星三联疗法根除率最高
  • 标准三联疗法在本网络荟萃分析中效果最差

研究设计与样本

  • 基于已发表随机对照试验的贝叶斯网络荟萃分析

主要发现

  • 仅伏诺拉生三联疗法和反向混合疗法总体根除率超过90%
  • 左氧氟沙星三联疗法在西方国家根除率为88.5%
  • 伏诺拉生三联疗法累积排名概率为92.4%,标准三联疗法为4.7%;比值比为3.80(95%可信区间1.62-8.94)

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: A number of double, triple, and quadruple therapies have been proposed as first-line empiric treatments for Helicobacter pylori infection. However, knowledge of their worldwide and regional comparative efficacy is lacking. We examined the comparative effectiveness of all empirically used first-line regimens tested against standard triple treatment using a network meta-analysis of published randomized controlled trials. METHODS: Data extracted from eligible randomized controlled trials were entered into a Bayesian network meta-analysis to investigate the comparative efficacy of H pylori infection empiric first-line regimens and to explore their effectiveness rank order. The ranking probability for each regimen was evaluated by means of surfaces under cumulative ranking values. RESULTS: Sixty-eight eligible randomized controlled trials were included, giving a total of 92 paired comparisons with 22,975 patients randomized to 8 first-line regimens. The overall results showed that only vonoprazan triple therapy and reverse hybrid therapy achieved cure rates of >90%. Levofloxacin triple therapy performed best in Western countries (eradication rate 88.5%). The comparative effectiveness ranking showed that vonoprazan triple therapy had the best results, whereas standard triple therapy was the least efficacious regimen (surfaces under cumulative ranking 92.4% vs 4.7% respectively; odds ratio, 3.80; 95% credible interval, 1.62-8.94). CONCLUSIONS: For first-line empiric treatment of H pylori infection, vonoprazan triple therapy and reverse hybrid therapy achieved high eradication rates of >90%. Levofloxacin triple therapy achieved the highest eradication rates in Western countries. Standard triple therapy was the least efficacious regimen in this network meta-analysis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Rokkas T, Gisbert JP, Malfertheiner P, et al. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis. Gastroenterology. 2021. PMID: 33839101. doi:10.1053/j.gastro.2021.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。